Rapid, direct detection of bacterial topoisomerase 1-DNA adducts by RADAR/ELISA

Copyright © 2020 Elsevier Inc. All rights reserved..

Topoisomerases are proven drug targets, but antibiotics that poison bacterial Topoisomerase 1 (Top1) have yet to be discovered. We have developed a rapid and direct assay for quantification of Top1-DNA adducts that is suitable for high throughput assays. Adducts are recovered by "RADAR fractionation", a quick, convenient approach in which cells are lysed in chaotropic salts and detergent and nucleic acids and covalently bound adducts then precipitated with alcohol. Here we show that RADAR fractionation followed by ELISA immunodetection can quantify adducts formed by wild-type and mutant Top1 derivatives encoded by two different bacterial pathogens, Y. pestis and M. tuberculosis, expressed in E. coli or M. smegmatis, respectively. For both enzymes, quantification of adducts by RADAR/ELISA produces results comparable to the more cumbersome classical approach of CsCl density gradient fractionation. The experiments reported here establish that RADAR/ELISA assay offers a simple way to characterize Top1 mutants and analyze kinetics of adduct formation and repair. They also provide a foundation for discovery and optimization of drugs that poison bacterial Top1 using standard high-throughput approaches.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:608

Enthalten in:

Analytical biochemistry - 608(2020) vom: 01. Nov., Seite 113827

Sprache:

Englisch

Beteiligte Personen:

Sinha, Devapriya [VerfasserIn]
Kiianitsa, Kostantin [VerfasserIn]
Sherman, David R [VerfasserIn]
Maizels, Nancy [VerfasserIn]

Links:

Volltext

Themen:

Antibiotic
Bacterial Proteins
Comparative Study
DNA Adducts
DNA Topoisomerases, Type I
DNA-Protein crosslink
EC 5.99.1.2
Gyrase
Journal Article
Mycobacteria
Research Support, N.I.H., Extramural
Topoisomerase poison
Tuberculosis

Anmerkungen:

Date Completed 30.04.2021

Date Revised 16.07.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ab.2020.113827

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM31313684X